Drug intelligence / Profile preview

multi-trace elements injection III

Development stage
Unknown
Lead developer
American Regent
Modality
Small Molecules
Administration
Intravenous
01

Overview

Multi-trace elements injection III is a sterile, concentrated solution of essential trace elements developed by Fresenius Kabi for intravenous administration. It is primarily indicated as a supplement to parenteral nutrition in adult patients to prevent or treat trace element deficiencies. The formulation typically contains nine essential elements: iron, zinc, manganese, copper, chromium, selenium, molybdenum, iodine, and fluorine. These elements serve as critical cofactors for a wide array of metabolic enzymes, contribute to the structural integrity of proteins like hemoglobin, and participate in antioxidant defense mechanisms. By providing these micronutrients directly into the systemic circulation, the injection ensures the maintenance of physiological functions in patients with impaired gastrointestinal absorption or those requiring long-term nutritional support.

Brand names
Addamel N
Other names
Multi-Trace Elements Injection 3多种微量元素注射液(III)
02

Targets

Misfolded SOD1INSR (Insulin receptor)TPO (Thyroid peroxidase)XO (Xanthine Oxidoreductase)GPX4 (Glutathione peroxidase 4)COX7C (Cytochrome c oxidase subunit 7C, mitochondrial)

Beyond the preview

Go deeper on multi-trace elements injection III.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on multi-trace elements injection III.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call